Načítá se...
HGG-43. SUSTAINED RESPONSE OF THREE PEDIATRIC BRAF(V600E) MUTATED HIGH-GRADE GLIOMAS WITH BRAF AND MEK INHIBITOR THERAPY
BACKGROUND: Treating high-grade gliomas in pediatric patients involves multimodal therapy with significant long-term sequelae. Despite this approach, these tumors have a high rate of recurrence. Genetic testing has allowed for targeted therapies to be investigated in tumors with BRAF(V600E) mutation...
Uloženo v:
| Vydáno v: | Neuro Oncol |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6012624/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.314 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|